Similar Articles
1911 Current systemic treatment of hepatocellular carcinoma: A review of the literature
1912 Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
1913 Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives
1914 Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9
1915 Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis
1916 Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy
1917 Antioxidant drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: What does evidence suggest?
1918 Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome
1919 Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives
1920 Intermediate hepatocellular carcinoma: How to choose the best treatment modality?
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA